Clinical Trials Logo

Filter by:
NCT ID: NCT05702424 Active, not recruiting - Solid Tumor Clinical Trials

Evaluation of IGM-7354 in Adults With Relapsed and/or Refractory Cancer

Start date: January 10, 2023
Phase: Phase 1
Study type: Interventional

This study is a first-in-human (FIH), Phase 1, multicenter, open-label study to evaluate the safety, tolerability, and PK of IGM-7354 in participants with relapsed and/or refractory tumors. The study design consists of a dose-escalation stage and dose-expansion stage. Study participation will consist of a 28-day screening period, a treatment period, and a safety follow-up period 90-days after the last dose.

NCT ID: NCT05701995 Active, not recruiting - Psoriasis Clinical Trials

A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting

ARTISTYK
Start date: January 31, 2023
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the effect of deucravacitinib on quality of life (QoL) in participants with plaque psoriasis in a community setting.

NCT ID: NCT05701800 Active, not recruiting - Herpes Zoster Clinical Trials

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ≥50 Years of Age

Start date: January 23, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

The main purpose of this first-in-human study is to generate sufficient safety and immunogenicity data to enable the selection of an appropriate dose level for the initiation of a Phase 2/3 study.

NCT ID: NCT05701774 Active, not recruiting - Clinical trials for Prader-Willi Syndrome

Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome

Start date: January 31, 2023
Phase: Phase 3
Study type: Interventional

The purpose of this is study is to evaluate the long-term safety of DCCR (diazoxide choline) extended-release tablets) in patients with Prader-Willi syndrome.

NCT ID: NCT05700747 Active, not recruiting - Multiple Myeloma Clinical Trials

Health Through Activity: A Pilot Study of a Rehabilitation Intervention for People Living With Multiple Myeloma

Start date: February 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to explore whether a structured program can help reduce the challenges of decreased physical functioning and quality of life for participants with multiple myeloma by providing a customized exercise program and fostering engagement in meaningful activities. The name of the study intervention involved in this study is: Health Through Activity (HTA) (six-session, rehabilitation exercise regimen)

NCT ID: NCT05700643 Active, not recruiting - Inflammation Clinical Trials

Montmorency Cherry Supplementation, Sleep, and Inflammation

Start date: February 18, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

This study will test the effects of Montmorency cherry supplementation on sleep outcomes and inflammatory biomarkers.

NCT ID: NCT05700383 Active, not recruiting - Chronic Pain Clinical Trials

The Thrive Study: Improving Multimodal Physical Function in Adults With Heterogenous Chronic Pain

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

The investigators aim to conduct a randomized controlled trial to test the feasibility of a mind-body walking program compared to a health education program for individuals with chronic musculoskeletal pain. The investigators will assess the feasibility of recruitment procedures (enrollment, recruitment of racial and ethnic minorities) and intervention delivery (fidelity, adherence, credibility, satisfaction, optimization), following pre-specified benchmarks. Both programs will be delivered in-person.

NCT ID: NCT05699460 Active, not recruiting - Parkinson's Disease Clinical Trials

Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy

Start date: September 29, 2022
Phase:
Study type: Observational

The objective of this study is to describe disease progression in study participants diagnosed with early Parkinson's Disease or Multiple System Atrophy - Parkinsonian Type up to 18 months as delineated by clinical and biochemical parameters.

NCT ID: NCT05698485 Active, not recruiting - Wrinkle Clinical Trials

The Effects of a 3-Part Skin Care Regimen on Facial Wrinkles and Biophysical Attributes

Start date: February 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to analyze various cosmetic endpoints, subjective assessments, and skin parameters such as hydration, transepidermal water loss, fine lines, and wrinkles with the use of a 3-part skin care regimen.

NCT ID: NCT05698290 Active, not recruiting - Pain Clinical Trials

HELP Pain Training Program

Start date: August 25, 2022
Phase:
Study type: Observational

The aim of this project is to develop and test the Helping Educators Learn Pediatric Pain Assessment & Intervention Needs (HELP Pain) program. HELP Pain provides training for school providers (e.g., school nurses, mental health professionals) on strategies to assess and manage pain-related concerns in school children. Participants will learn cognitive behavioral therapy techniques to help school children manage pain, and report on their use of strategies, and child's progress throughout the school year. Follow-up data will be collected in year 2.